BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 15756711)

  • 1. Replication-dependent transgene expression from a conditionally replicating adenovirus via alternative splicing to a heterologous splice-acceptor site.
    Carette JE; Graat HC; Schagen FH; Abou El Hassan MA; Gerritsen WR; van Beusechem VW
    J Gene Med; 2005 Aug; 7(8):1053-62. PubMed ID: 15756711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the E3 and L3 regions for arming oncolytic adenoviruses to achieve a high level of tumor-specific transgene expression.
    Robinson M; Ge Y; Ko D; Yendluri S; Laflamme G; Hawkins L; Jooss K
    Cancer Gene Ther; 2008 Jan; 15(1):9-17. PubMed ID: 17853920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel insertion sites in the Ad5 genome that utilize the Ad splicing machinery for therapeutic gene expression.
    Jin F; Kretschmer PJ; Hermiston TW
    Mol Ther; 2005 Dec; 12(6):1052-63. PubMed ID: 16165398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mode of transgene expression after fusion to early or late viral genes of a conditionally replicating adenovirus via an optimized internal ribosome entry site in vitro and in vivo.
    Rivera AA; Wang M; Suzuki K; Uil TG; Krasnykh V; Curiel DT; Nettelbeck DM
    Virology; 2004 Mar; 320(1):121-34. PubMed ID: 15003868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.
    Hu ZB; Wu CT; Wang H; Zhang QW; Wang L; Wang RL; Lu ZZ; Wang LS
    Cancer Gene Ther; 2008 Mar; 15(3):173-82. PubMed ID: 18157145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulated hsp70B' promoter: stringent heat-inducible activity in replication-deficient, but not replication-competent adenoviruses.
    Rohmer S; Mainka A; Knippertz I; Hesse A; Nettelbeck DM
    J Gene Med; 2008 Apr; 10(4):340-54. PubMed ID: 18265421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus.
    Liu TC; Wang Y; Hallden G; Brooks G; Francis J; Lemoine NR; Kirn D
    Gene Ther; 2005 Sep; 12(17):1333-46. PubMed ID: 15920462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
    Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X
    J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of telomerase promoter tumor selectivity in the context of oncolytic adenoviruses.
    Bilsland AE; Merron A; Vassaux G; Keith WN
    Cancer Res; 2007 Feb; 67(3):1299-307. PubMed ID: 17283167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linked tumor-selective virus replication and transgene expression from E3-containing oncolytic adenoviruses.
    Zhu M; Bristol JA; Xie Y; Mina M; Ji H; Forry-Schaudies S; Ennist DL
    J Virol; 2005 May; 79(9):5455-65. PubMed ID: 15827160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive visualization of adenovirus replication with a fluorescent reporter in the E3 region.
    Ono HA; Le LP; Davydova JG; Gavrikova T; Yamamoto M
    Cancer Res; 2005 Nov; 65(22):10154-8. PubMed ID: 16287998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effects of oncolytic adenovirus armed with Drosophila melanogaster deoxyribonucleoside kinase in colorectal cancer.
    Ma S; Qu W; Mao L; Zhu Z; Jia L; Zhao L; Zheng X
    Oncol Rep; 2012 May; 27(5):1443-50. PubMed ID: 22294034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selectivity and efficiency of late transgene expression by transcriptionally targeted oncolytic adenoviruses are dependent on the transgene insertion strategy.
    Quirin C; Rohmer S; Fernández-Ulibarri I; Behr M; Hesse A; Engelhardt S; Erbs P; Enk AH; Nettelbeck DM
    Hum Gene Ther; 2011 Apr; 22(4):389-404. PubMed ID: 20939692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple-targeted oncolytic adenoviruses featuring the cox2 promoter, E1A transcomplementation, and serotype chimerism for enhanced selectivity for ovarian cancer cells.
    Bauerschmitz GJ; Guse K; Kanerva A; Menzel A; Herrmann I; Desmond RA; Yamamoto M; Nettelbeck DM; Hakkarainen T; Dall P; Curiel DT; Hemminki A
    Mol Ther; 2006 Aug; 14(2):164-74. PubMed ID: 16580264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of the E3-6.7K/gp19K region reduces the persistence of wild-type adenovirus in a permissive tumor model in Syrian hamsters.
    Bortolanza S; Bunuales M; Alzuguren P; Lamas O; Aldabe R; Prieto J; Hernandez-Alcoceba R
    Cancer Gene Ther; 2009 Sep; 16(9):703-12. PubMed ID: 19229289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bidirectional Tet-dependent promotor construct regulating the expression of E1A for tight control of oncolytic adenovirus replication.
    Fechner H; Wang X; Picó AH; Wildner J; Suckau L; Pinkert S; Sipo I; Weger S; Poller W
    J Biotechnol; 2007 Jan; 127(4):560-74. PubMed ID: 17083991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Luciferase imaging for evaluation of oncolytic adenovirus replication in vivo.
    Guse K; Dias JD; Bauerschmitz GJ; Hakkarainen T; Aavik E; Ranki T; Pisto T; Särkioja M; Desmond RA; Kanerva A; Hemminki A
    Gene Ther; 2007 Jun; 14(11):902-11. PubMed ID: 17377596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A three-plasmid system for construction of armed oncolytic adenovirus.
    Liu HY; Han BJ; Zhong YX; Lu ZZ
    J Virol Methods; 2009 Dec; 162(1-2):8-13. PubMed ID: 19646479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue inhibitor of metalloproteinase-3 expression from an oncolytic adenovirus inhibits matrix metalloproteinase activity in vivo without affecting antitumor efficacy in malignant glioma.
    Lamfers ML; Gianni D; Tung CH; Idema S; Schagen FH; Carette JE; Quax PH; Van Beusechem VW; Vandertop WP; Dirven CM; Chiocca EA; Gerritsen WR
    Cancer Res; 2005 Oct; 65(20):9398-405. PubMed ID: 16230403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of cancer with a novel dual-targeted conditionally replicative adenovirus armed with mda-7/IL-24 gene.
    Luo J; Xia Q; Zhang R; Lv C; Zhang W; Wang Y; Cui Q; Liu L; Cai R; Qian C
    Clin Cancer Res; 2008 Apr; 14(8):2450-7. PubMed ID: 18413837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.